World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
103
Citations
45472
World Ranking
7278
National Ranking
709

Michael G. Hanna publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Michael G. Hanna sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 861 publications — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Michael G. Hanna D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Michael G. Hanna sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 103 D-Index — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Michael G. Hanna is affiliated with University College London in the United Kingdom. Their research spans multiple fields of study, primarily within medicine and biochemistry, genetics, and molecular biology.

Their work covers a number of subfields including molecular biology, genetics, cellular and molecular neuroscience, cardiology and cardiovascular medicine, and neurology. These areas reflect a diverse focus on both fundamental biological processes and clinical applications.

Main topics of research addressed by Michael G. Hanna include:

  • Genetic Neurodegenerative Diseases
  • Mitochondrial Function and Pathology
  • Ion channel regulation and function
  • Muscle Physiology and Disorders
  • Metabolism and Genetic Disorders
  • Genomics and Rare Diseases
  • Inflammatory Myopathies and Dermatomyositis

They have contributed numerous publications within several key academic journals. Frequent publication venues are:

  • Neuromuscular Disorders
  • Muscle & Nerve
  • Brain
  • Journal of Neurology Neurosurgery & Psychiatry
  • bioRxiv (Cold Spring Harbor Laboratory)

Michael G. Hanna collaborates regularly with a group of coauthors, among whom the most frequent are:

  • Robert D. S. Pitceathly
  • Henry Houlden
  • Emma Matthews
  • Enrico Bugiardini
  • Pedro Machado

Some of their recent papers demonstrate the range of their research interests and contributions. These include:

  • Cardiolipin, Mitochondria, and Neurological Disease (2021), published in Trends in Endocrinology and Metabolism
  • British Society for Rheumatology guideline on management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy (2022), published in Lara D. Veeken
  • Guidelines on clinical presentation and management of nondystrophic myotonias (2020), published in Muscle & Nerve
  • Use of whole genome sequencing to determine genetic basis of suspected mitochondrial disorders: cohort study (2021), published in BMJ
  • Solving patients with rare diseases through programmatic reanalysis of genome-phenome data (2021), published in European Journal of Human Genetics

Best Publications

  • Apixaban versus Warfarin in Patients with Atrial Fibrillation

    Christopher B. Granger;John H. Alexander;Renato D. Lopes;Elaine M. Hylek

  • Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial.

    Stefan H. Hohnloser;Ziad Hijazi;Laine Thomas;John H. Alexander

  • Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial

    Jan B Vermorken;Anke M E Claessen;Harm van Tinteren;Helen E Gall

  • Apixaban for Reduction In Stroke and Other ThromboemboLic Events in Atrial Fibrillation (ARISTOTLE) trial: Design and rationale

    Renato D. Lopes;John H. Alexander;Sana M. Al-Khatib;Jack Ansell

  • Exercise Intolerance Due to Mutations in the Cytochrome b Gene of Mitochondrial DNA

    Antoni L. Andreu;Michael G. Hanna;Heinz Reichmann;Claudio Bruno

  • Human epilepsy associated with dysfunction of the brain P/Q-type calcium channel

    Anne Jouvenceau;Anne Jouvenceau;Louise H Eunson;Alexander Spauschus;Alexander Spauschus;Venkataswaran Ramesh

  • Phenotypic spectrum associated with mutations of the mitochondrial polymerase γ gene

    R Horvath;G Hudson;G Ferrari;N Futterer

  • Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial.

    Sigrun Halvorsen;Dan Atar;Dan Atar;Hongqiu Yang;Raffaele De Caterina

  • The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation

    Ziad Hijazi;Johan Lindbäck;John H. Alexander;Michael Hanna

  • A novel mutation in the human voltage-gated potassium channel gene (Kv1.1) associates with episodic ataxia type 1 and sometimes with partial epilepsy.

    S. M. Zuberi;L. H. Eunson;A. Spauschus;R. De Silva

  • The primary periodic paralyses: diagnosis, pathogenesis and treatment

    S. L. Venance;S. C. Cannon;D. Fialho;B. Fontaine

  • Major Bleeding in Patients With Atrial Fibrillation Receiving Apixaban or Warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, Characteristics, and Clinical Outcomes

    Elaine M. Hylek;Claes Held;John H. Alexander;Renato D. Lopes

  • Primary episodic ataxias: diagnosis, pathogenesis and treatment.

    J.C. Jen;T.D. Graves;E.J. Hess;M.G. Hanna

  • Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial.

    J Donald Easton;Renato D Lopes;M Cecilia Bahit;Daniel M Wojdyla

  • Growth Differentiation Factor 15, a Marker of Oxidative Stress and Inflammation, for Risk Assessment in Patients With Atrial Fibrillation Insights From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial

    Lars Wallentin;Ziad Hijazi;Ulrika Andersson;John H. Alexander

  • International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease.

    D. A. Isenberg;E. Allen;V. Farewell;M. R. Ehrenstein

  • MRI biomarker assessment of neuromuscular disease progression: a prospective observational cohort study

    Jasper M Morrow;Christopher D J Sinclair;Arne Fischmann;Arne Fischmann;Pedro M Machado

  • Clinical, genetic, and expression studies of mutations in the potassium channel gene KCNA1 reveal new phenotypic variability

    L. H. Eunson;R. Rea;S. M. Zuberi;S. Youroukos

  • Mutations in the Gene PRRT2 Cause Paroxysmal Kinesigenic Dyskinesia with Infantile Convulsions

    Hsien Yang Lee;Yong Huang;Yong Huang;Nadine Bruneau;Patrice Roll

  • Phenotypic spectrum associated with mutations of the mitochondrial polymerase γ gene. Commentary

    Salvatore Dimauro;Guido Davidzon;Michio Hirano;Rita Horvath

Frequent Co-Authors

Mary M. Reilly
Mary M. Reilly University College London
Renato D. Lopes
Renato D. Lopes Duke University
John H. Alexander
John H. Alexander Duke University
Christopher B. Granger
Christopher B. Granger Duke University
Lars Wallentin
Lars Wallentin Uppsala University
Dimitri M. Kullmann
Dimitri M. Kullmann University College London
Francesco Muntoni
Francesco Muntoni University College London
Janice L. Holton
Janice L. Holton University College London
Henry Houlden
Henry Houlden University College London
Tarek A. Yousry
Tarek A. Yousry University College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Medicine in the USA opens doors to a variety of rewarding healthcare careers beyond traditional medical school. Many students consider nursing, and for some, finding what is the easiest nursing school to get into can be a practical route into the profession. Some nursing programs even offer admission without entrance tests, so researching nursing school no entrance exam options may accelerate your journey.

Not all healthcare careers require direct patient care. Administrative and technical fields, such as medical billing, coding, and healthcare management, are also in high demand. For those seeking convenient and affordable study, consider medical billing and coding online schools that accept financial aid. Pursuing a recognized management credential can further broaden your options; many choose a healthcare administration degree online accredited for flexibility and career advancement.

With diverse online pathways and accessible programs, you can start your healthcare journey in the way that works best for you. Thorough research ensures you find accredited programs, financial support, and a pathway that aligns with your goals.

Best Scientists Citing Michael G. Hanna

Trending Scientists

Recently Published Articles